Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) EBIT (2018 - 2025)

Historic EBIT for Evolus (EOLS) over the last 8 years, with Q3 2025 value amounting to -$11.5 million.

  • Evolus' EBIT rose 2567.7% to -$11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.2 million, marking a year-over-year increase of 377.1%. This contributed to the annual value of -$34.4 million for FY2024, which is 3010.58% up from last year.
  • Latest data reveals that Evolus reported EBIT of -$11.5 million as of Q3 2025, which was up 2567.7% from -$10.2 million recorded in Q2 2025.
  • In the past 5 years, Evolus' EBIT registered a high of $8.0 million during Q1 2021, and its lowest value of -$21.3 million during Q2 2022.
  • Moreover, its 5-year median value for EBIT was -$13.4 million (2023), whereas its average is -$12.1 million.
  • In the last 5 years, Evolus' EBIT surged by 14613.97% in 2021 and then tumbled by 29247.45% in 2022.
  • Quarter analysis of 5 years shows Evolus' EBIT stood at -$18.0 million in 2021, then soared by 41.0% to -$10.6 million in 2022, then grew by 18.82% to -$8.6 million in 2023, then surged by 73.2% to -$2.3 million in 2024, then plummeted by 396.97% to -$11.5 million in 2025.
  • Its EBIT was -$11.5 million in Q3 2025, compared to -$10.2 million in Q2 2025 and -$15.2 million in Q1 2025.